A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Clinical trial NCT00986661 · UNKNOWN

Trial details

NCT number: NCT00986661
Sponsor: Provectus Biopharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Metastatic to the Liver Hepatocellular Carcinoma Metastatic Melanoma Metastatic Ocular Melanoma Metastatic Uveal Melanoma Metastatic Lung Cancer Metastatic Colon Cancer Metastatic Colorectal Cancer Metastatic Breast Cancer Metastatic Pancreatic Cancer

Start date: 2009-10-01
Primary completion: 2022-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.